TY  -  
T1  - Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study 
SN  -  /  
UR  - http://hdl.handle.net/10138/320179 
T3  -  
A1  - Hietikko, Ronja; Kilpeläinen, Tuomas P; Kenttämies, Anu; Ronkainen, Johanna; Ijäs, Kirsty; Lind, Kati; Marjasuo, Suvi; Oksala, Juha; Oksanen, Outi; Saarinen, Tuomas; Savolainen, Ritja; Taari, Kimmo; Tammela, Teuvo L J; Mirtti, Tuomas; Natunen, Kari; Auvinen, Anssi; Rannikko, Antti 
A2  -  
PB  - BioMed Central 
Y1  - 2020 
LA  -  
AB  - Abstract
              
                Background
                The aim of this study is to investigate the potential impact of prostate magnetic resonance imaging (MRI) -related interreader variability on a population-based randomized prostate cancer screening trial (ProScreen).
              
              
                Methods
                From January 2014 to January 2018, 100 men aged 50–63 years with clinical suspicion of prostate cancer (PCa) in Helsinki University Hospital under... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Prostate cancer; Agreement; Magnetic resonance imaging; PI-RADS version 2; Screening 
N1  -   
PP  -  
ER  -